Israeli biotech Clearmind Medicine appoints former Red Bull executive special advisor for development of MEAI as an alcohol substitute | MarketScreener
Nicholas Kadysh, a former Red Bull Canada and Juul Labs Canada executiveis an expert in regulatory matters VANCOUVER, December 09, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (CSE: CMND), (FSE: CWY) (“clear mind“or the”vsinsult“), a biotechnology company focused on the discovery and development of novel psychedelic-derived therapies to address major undertreated health issues, …
